These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Protection of hospital personnel against risks of exposure to blood]. Bouvet E; Tarantola A Rev Prat; 1998 Sep; 48(14):1558-62. PubMed ID: 9814052 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)]. Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353 [TBL] [Abstract][Full Text] [Related]
7. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system. Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602 [TBL] [Abstract][Full Text] [Related]
8. [Virus safety of fresh frozen plasma]. Sugg U Beitr Infusionsther; 1989; 24():56-9. PubMed ID: 2481549 [TBL] [Abstract][Full Text] [Related]
9. Viral infections transmitted by blood and its products. Barbara JA; Tedder RS Clin Haematol; 1984 Oct; 13(3):693-707. PubMed ID: 6094064 [TBL] [Abstract][Full Text] [Related]
12. Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products. Roberts P Biologicals; 2000 Mar; 28(1):29-32. PubMed ID: 10799053 [TBL] [Abstract][Full Text] [Related]
13. [Risk of infection caused by homologous blood transfusion]. Kühnl P; Löliger C; Laufs R Chirurg; 1994 Dec; 65(12):1071-4. PubMed ID: 7851137 [TBL] [Abstract][Full Text] [Related]
15. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system. Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321 [TBL] [Abstract][Full Text] [Related]
16. [Viral safety in hemotherapy. Current aspects of hepatitis C and parvovirus B19 detection for plasma component therapy]. Sibrowski W; Kühnl P Beitr Infusionsther; 1990; 26():22-6. PubMed ID: 1703836 [TBL] [Abstract][Full Text] [Related]
17. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820 [TBL] [Abstract][Full Text] [Related]
18. Virus inactivation in a factor VIII/VWF concentrate treated using a solvent/detergent procedure based on polysorbate 20. Roberts PL; Lloyd D; Marshall PJ Biologicals; 2009 Jan; 37(1):26-31. PubMed ID: 18848782 [TBL] [Abstract][Full Text] [Related]
19. [Indications for fresh frozen plasma: evaluation of virus inactivating preparations]. Pindur G; Kiesewetter H; Seyfert UT; Wenzel E Beitr Infusionsther; 1993; 31():74-80. PubMed ID: 7693268 [TBL] [Abstract][Full Text] [Related]
20. Beyond HIV, HBV and HCV--how to deal with other viruses? Minor PD Dev Biol (Basel); 2002; 108():15-9. PubMed ID: 12220138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]